Abstract
Effects of compounds of the okadaic acid type (okadaic acid, dinophysistoxin-1, calyculin A and tautomycin) on proliferation by digestive-tract epithelial cells were investigated in mice and rats. In mice, a single oral administration of these agents caused significant enhancement of BrdU labeling indices in a dose/response manner. Exceptions showing no response were limited to the pyloric mucosa for okadaic acid, the pyloric and fundic mucosa for calyculin A and the pyloric mucosa for tautomycin. Sequential analysis of labeling indices after a single oral administration of dinophysistoxin-1 revealed two peaks of cell proliferation at 18 h and 36 h in the esophagus, ileum and colon. The labeling indices of the forestomach, fundus, pylorus and jejunum, on the other hand, continuously increased from 6 h after the administration. Elevated proliferation was also observed in the skin after 30 h or after, but no effects on the liver or kidney were evident. A single oral administration of the okadaic acid type of compounds also dose-dependently enhanced cell proliferation of the rat digestive tract. These results strongly suggest that the okadaic acid class of compounds may exert promoting potential for the gastrointestinal mucosa when administered orally.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Edebo L, Lange S, Li XP, Allenmark S, Jennishe E (1989) Diarrhetic shellfish toxins induce rapid swelling of the intestinal epithelium and hypersecretion in the rat small intestine. In: Natori S, Hashimoto K, Ueno Y (eds) Mycotoxins and phycotoxins. Elsevier: Amsterdam, pp 437–444
Fabrikant JI (1967) The spatial distribution of parenchymal cell proliferation during regeneration of the liver. Johns Hopkins Med Bull 120:147–147
Fujiki H (1992) Is the inhibition of protein phosphatase 1 and 2A activities a general mechanism of tumor promotion in human cancer development? Mol Carcinog 5:91–94
Fujiki H, Suganuma M (1993) Tumor promotion by inhibitors of protein phosphatases 1 and 2A, the okadaic acid class compounds. Adv Cancer Res 61:143–194
Fujiki H, Suganuma M, Suguri H, Yoshizawa S, Takagi K, Uda N, Wakamatsu K, Yamada K, Murata M, Yasumoto T, Sugimura T (1988) Diarrhetic shellfish toxin, dinophysistoxin-1, is a potent tumor promoter on mouse skin. Jpn J Cancer Res (Gann) 79:1089–1093
Herschman HR, Lim RW, Branknow W, Fujiki H (1989) The tumor promoters 12-O-tetradecanoylphorbol-13-acetate and okadaic acid differ in toxicity, mitogenic activity and induction of gene expression. Carcinogenesis 10:1495–1498
Holladay K, Fujiki H, Bowden GT (1992) Okadaic acid induces the expression of both early and secondary response genes in mouse keratocytes. Mol Carcinog 5:16–24
Murata M, Shimatani M, Sugitani H, Oshima Y, Yasumoto T (1982) Isolation and structure elucidation of the causative toxin of the diarrhetic shellfish poisoning. Bull Jpn Soc Sci Fish 48:549–552
Nishiwaki-Matsushima R, Ohta T, Nishiwaki S, Suganuma M, Kohyama K, Ishikawa T, Carmichael WW, Fujiki H (1992) Liver tumor promotion by the cyanobacterial cyclic peptide toxin microcystin-LR. J Cancer Res Clin Oncol 118:420–424
Pardee AB, Coppock DL, Yang HC (1986) Regulation of cell proliferation at the onset of DNA synthesis. J Cell Sci Suppl 4:171–180
Schonthal A, Tsukitani Y, Feramisco J (1991a) Transcriptional and posttranscriptional regulation of c-fos proto-oncogene expression by the tumor promoter okadaic acid. Oncogene 6:423–430
Schonthal A, Alberts AS, Frost JA, Feramisco JR (1991b) Differential regulation ofjun family gene expression by the tumor promoter okadaic acid. New Biol 3:977–986
Suganuma M, Fujiki H, Suguri H, Yoshizawa S, Hirota M, Nakayasu M, Ojika M, Wakamatsu K, Yamada K, Sugimura T (1988) Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter. Proc Natl Acad Sci USA 85:1768–1771
Suganuma M, Fujiki H, Suguri HF, Yoshizawa S, Yasumoto S, Kato Y, Fusetani N, Sugimura T (1990) Calyculin A, an inhibitor of protein phosphatases, a potent tumor promoter on CD-1 mouse skin. Cancer Res 50:3521–3525.
Suganuma M, Fujiki H, Okabe S, Nishiwaki S, Brautigan D, Ingebritsen SI, Rosner MR (1992a) Structurally different members of the okadaic acid class selectively inhibit protein serine/threonine but not tyrosine phosphatase activity. Toxicon 30:873–878
Suganuma M, Tatematsu M, Yatsunami J, Yoshizawa S, Okabe S, Uemura D, Fujiki H (1992b) An alternative theory of tissue specificity by tumor promotion of okadaic acid in glandular stomach of SD rats. Carcinogenesis 13:1841–1845
Terao K, Ito E, Yanagi T, Yasumoto T (1986) Histopathological studies on experimental marine toxin poisoning. I. Ultrastructural changes in the small intestine and liver of suckling mice induced by dinophysistoxin-1 and pectenotoxin-1. Toxicon 24:1141–1151
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yuasa, H., Yoshida, K., Iwata, H. et al. Increase of labeling indices in gastrointestinal mucosae of mice and rats by compounds of the okadaic acid type. J Cancer Res Clin Oncol 120, 208–212 (1994). https://doi.org/10.1007/BF01372558
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01372558